Key facts
- This page summarizes Meredith Williamson's Form 4 filing for EQUINIX INC (EQIX).
- 10 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Sep 2024, 17:32.
Meredith Williamson - 03 Sep 2024 Form 4 Insider Report for EQUINIX INC (EQIX)
- Reporting relationship
- Chief Customer & Rev Officer
- Issuer ticker
- EQIX
- Reported as of
- 03 Sep 2024
- Net transaction value
- -$474,736
- SEC form
- 4
- Accepted by SEC
- 05 Sep 2024, 17:32:47 UTC
- Prior SEC filing
- 27 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Samantha Lagocki, POA
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Meredith Williamson filed Form 4 for EQUINIX INC (EQIX) on 05 Sep 2024.
Change
- Previous filing in this sequence was filed on 27 Mar 2024.
- Current net transaction value: -$474,736.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EQIX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +576
- Change %
- Price
- $0.000000
- Shares after
- 576
- Date
- 03 Sep 2024
- Ownership
- Direct
EQIX
transaction
Common Stock
Sale
- Transaction value
- $98,229
- Shares
- -120
- Change %
- -21%
- Price
- $818.57
- Shares after
- 456
- Date
- 04 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F2
EQIX
transaction
Common Stock
Sale
- Transaction value
- $17,218
- Shares
- -21
- Change %
- -4.6%
- Price
- $819.91
- Shares after
- 435
- Date
- 04 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F3
EQIX
transaction
Common Stock
Sale
- Transaction value
- $11,489
- Shares
- -14
- Change %
- -3.2%
- Price
- $820.64
- Shares after
- 421
- Date
- 04 Sep 2024
- Ownership
- Direct
- Footnotes
- F1
EQIX
transaction
Common Stock
Sale
- Transaction value
- $69,119
- Shares
- -84
- Change %
- -20%
- Price
- $822.85
- Shares after
- 337
- Date
- 04 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F4
EQIX
transaction
Common Stock
Sale
- Transaction value
- $23,063
- Shares
- -28
- Change %
- -8.3%
- Price
- $823.67
- Shares after
- 309
- Date
- 04 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F5
EQIX
transaction
Common Stock
Sale
- Transaction value
- $138,852
- Shares
- -168
- Change %
- -54%
- Price
- $826.50
- Shares after
- 141
- Date
- 04 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F6
EQIX
transaction
Common Stock
Sale
- Transaction value
- $70,354
- Shares
- -85
- Change %
- -60%
- Price
- $827.69
- Shares after
- 56
- Date
- 04 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F7
EQIX
transaction
Common Stock
Sale
- Transaction value
- $46,412
- Shares
- -56
- Change %
- -100%
- Price
- $828.78
- Shares after
- 0
- Date
- 04 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F8
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EQIX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -576
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 1,151
- Date
- 03 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 576
- Exercise price
- $0.000000
- Footnotes
- F9, F10
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 10 footnotes
Footnote F1
Shares sold pursuant to a 10b5-1 Trading Plan.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.51 to $819.36, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 8 to this Form 4.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $819.62 to $820.16 inclusive.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $822.32 to $823.23 inclusive.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $823.33 to $823.99 inclusive.
Footnote F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $826.26 to $827.09 inclusive.
Footnote F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $827.41 to $828.21 inclusive.
Footnote F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $828.73 to $828.84 inclusive.
Footnote F9
Vesting is dependent upon continuous active service as an employee or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vesting on September 1, 2024 and an additional 16.67% of the RSUs vesting every 6 months thereafter until fully vested.
Footnote F10
Restricted stock unit award expires upon reporting person's termination of service.